Cutler Group LP Regenxbio Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	BUY	$12.17 - $24.61 $9,736 - $19,688	800 Added 61.54%	2,100 $2,000
Q4 2023 Jan 18, 2024	BUY	$12.89 - $20.82 $16,757 - $27,066	1,300 New	1,300 $4,000
Q2 2023 Jul 18, 2023	SELL	$17.23 - $21.71 $43,075 - $54,275	-2,500 Reduced 80.65%	600 $1,000
Q1 2023 May 01, 2023	SELL	$18.08 - $24.55 $3,615 - $4,910	-200 Reduced 6.06%	3,100 $0
Q4 2022 Feb 07, 2023	SELL	$20.4 - $24.73 $34,680 - $42,041	-1,700 Reduced 34.0%	3,300 $7,000
Q2 2022 Aug 04, 2022	BUY	$19.35 - $35.04 $79,335 - $143,664	4,100 Added 455.56%	5,000 $17,000
Q1 2021 Apr 26, 2021	BUY	$33.61 - $49.95 $30,249 - $44,955	900 New	900 $0
Q3 2020 Oct 27, 2020	SELL	$27.01 - $40.26 $29,711 - $44,286	-1,100 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$27.75 - $43.44 $52,725 - $82,536	-1,900 Reduced 63.33%	1,100 $0
Q1 2020 May 07, 2020	BUY	$21.5 - $54.2 $6,450 - $16,260	300 Added 11.11%	3,000 $2,000
Q3 2019 Oct 28, 2019	SELL	$31.84 - $50.88 $133,728 - $213,696	-4,200 Reduced 60.87%	2,700 $1,000
Q2 2019 Aug 09, 2019	SELL	$42.0 - $59.29 $142,800 - $201,586	-3,400 Reduced 33.01%	6,900 $11,000
Q1 2019 May 10, 2019	BUY	$40.82 - $62.45 $224,510 - $343,475	5,500 Added 114.58%	10,300 $62,000
Q4 2018 Feb 05, 2019	BUY	$39.11 - $75.15 $74,309 - $142,785	1,900 Added 65.52%	4,800 $1,000
Q3 2018 Nov 07, 2018	SELL	$65.0 - $82.15 $195,000 - $246,450	-3,000 Reduced 50.85%	2,900 $73,000
Q2 2018 Aug 10, 2018	SELL	$27.2 - $74.35 $160,480 - $438,664	-5,900 Reduced 50.0%	5,900 $215,000
Q1 2018 May 11, 2018	BUY	$24.05 - $37.5 $101,010 - $157,500	4,200 Added 55.26%	11,800 $10,000
Q4 2017 Jan 17, 2018	BUY	$26.0 - $34.6 $127,400 - $169,540	4,900 Added 181.48%	7,600 $60,000
Q3 2017 Oct 17, 2017	BUY	$18.0 - $32.95 $48,600 - $88,965	2,700	2,700 $16,000

Others Institutions Holding RGNX

# of Institutions

192

Shares Held

43.5M

Call Options Held

58.9K

Put Options Held

58.4K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $441M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account